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Patyal, Pankaj, M.S. Department of Pharmacology and Toxicology, Wright State 
University, 2015. Expression of Aquaporins in mouse choroid plexus and ependymal 
cells.  
 
The choroid plexuses (CPs) are highly vascularized epithelial structures lying in the brain 
ventricles, forming the blood-cerebrospinal fluid (CSF) barrier. CPs are composed of a 
monolayer of cuboidal epithelial cells, derived from ependymal cells (EPCs), joined by 
tight junctions, and surrounding a core of fenestrated capillaries. Choroid plexus 
epithelial cells (CPECs) secrete most of the CSF through poorly understood mechanisms 
that involve aquaporins (AQPs) and various solute transport proteins like the Na+-K+-2Cl- 
cotransporter 1 (NKCC1). It is thought that the concerted action of these membrane 
proteins directs the transepithelial movement of solutes and water across CPECs. Net 
water movement across CPECs occurs from the basolateral membrane (blood-facing) 
through the apical membrane (CSF-facing). However, with the exception of AQP1 in the 
apical membrane, the molecular pathways for transepithelial water transport are either 
unknown or their expression is controversial; there are no known AQPs in the basolateral 
membrane of CPECs to account for the influx of water, and whether AQPs other than 
AQP1 are expressed in the apical membrane remains to be elucidated. The expression of 
AQP1 in the basolateral membrane is a subject of debate. Previous work from our lab 
demonstrated strict apical localization of AQP1; its expression in the basolateral 
membrane of mouse CPECs is undetectable. Thus, AQPs other than AQP1 are potential 





besides AQP1 there are other AQPs in the apical membrane. In previous work from our 
group, transcripts for several AQPs were detected in whole choroid plexus tissue using 
RT-PCR. Specifically, mRNAs for AQP water channels 0, 1, 2, 4, aquaglyceroporins 3, 
7, 9, and “unorthodox” AQP11 were detected, whereas transcripts for AQPs 5, 6, 8, and 
12 were undetectable. Because of their relatively high transcript expression the present 
work addresses the cellular and subcellular location of AQPs 4, 7 and 9 proteins in 
CPECs and EP cells, using immunolabeling with validated antibodies and confocal 
immunofluorescence. AQP4 expression in CPECs is debatable. The present results 
demonstrate that: 1) AQP 4 is expressed neither in CPECs nor in ependymal cells, but in 
radial glial end feet surrounding the basal aspect of EPCs. Thus previous RT-PCR mRNA 
for AQ4 is likely to represent glial contamination during tissue extraction. 2) AQP 7 
expression was found to be restricted to the apical membrane of CPECs and EPCs. 3) 
AQP9 was expressed neither in CPECs nor in EPCs. The water pathways for water influx 
across the CPECs basolateral membrane remain to be elucidated. The functional 
significance of the present results for CSF secretion and brain extracellular K+ 
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The choroid plexuses (CPs) of the brain ventricles secrete cerebrospinal fluid 
(CSF) at a rate of about 600 milliliters per day. This high fluid transport rate is similar to 
that of the renal proximal tubules (Damkier et al., 2013). The CSF is constantly 
reabsorbed, so that only ~150 ml are present at any one time in the entire CNS, thus CSF 
is replaced four times per day. The CPs are highly vascularized epithelial structures that 
form the blood-cerebrospinal fluid barrier (BCSFB). The mechanisms of fluid secretion 
by the CPs are not understood. Moreover, the pathways through which water moves 
across the plasma membranes of choroid plexus epithelial cells (CPECs) are largely 
unknown. Given the relatively high rate of fluid secretion by the CPECs, water flow must 
occur through specialized plasma membrane proteins, such as aquaporins (AQPs), rather 
than through poorly water-permeable lipid bilayers (Friedman, 2008). The objective of 
this study was to analyze the protein expression of three of these aquaporins that are 
thought to exist in the CP, to determine if they might play a role in water flux across the 
BCSFB. 
Like other epithelial cells, CPECs are polarized; having an apical membrane 
(CSF-facing), and a basolateral membrane (blood-facing). Among many unanswered 
questions in CP function, are the mechanisms underlying transepithelial water transport.  
It is well established that aquaporin 1 (AQP1) is expressed in the apical membrane of 
CPECs (Nielsen et al., 1993). To date, there are no known AQPs in the basolateral 





secretion. Moreover, in AQP1 KO mice CSF secretion rate is reduced by only 25% 
(Oshio et al., 2003, 2005). Thus, AQPs other than AQP1 are potential molecular 
substrates for putative basolateral water influx. Further, it is not known if besides AQP1 
there are other AQPs in the apical membrane. The specific objective of the present study 
was to investigate the cellular and subcellular expression of AQPs 4, 7 and 9 proteins in 
CPECs and ependymal cells (EPCs), the cells that give rise to CPECs. 
CPs are composed of a monolayer of cuboidal epithelial cells derived from 
ependymal cells (EPCs), joined together near their apical lateral surface by tight junctions 
(Prescott and Brightman, 2005). The CPs surround a core of capillaries that are 
fenestrated and do not have tight junctions, unlike those forming the blood-brain barrier 
(BBB) that are not fenestrated and do have tight junctions. It is these features of CP 
capillaries that allow water and small solutes to move freely through the endothelia 
between the blood and basolateral membrane of the CPECs (Prescott and Brightman, 
2005).  
It is known that net transcellular water flux across CPECs occur from the 
basolateral membrane to the apical membrane i.e. from blood to the CSF, however the 
proteins and the mechanisms that carry out fluid secretion are largely unknown (Damkier 
et al., 2010, 2013). One of the main puzzles is that until now, putative AQPs have not 
been demonstrated in the basolateral membrane (Damkier et al., 2013). 
Transepithelial water transport, in general, can occur through transcellular and 
paracellular routes (Friedman, 2008). The paracellular transport route refers to the 
transfer of solute and fluid through the intercellular spaces between the cells, via tight 





passing through both apical and basolateral membranes (Friedman, 2008; Damkier et al., 
2013). In CPECs it is thought that water movement occurs mainly, if not exclusively, 
through transcellular pathways, but so far, possible paracellular pathways have not been 
investigated (Damkier et al., 2013). There is evidence for paracellular water transport 
across MDCK C7 epithelial monolayer cultures stably transfected with claudin-2, a tight 
junction protein (Rosenthal et al., 2010). Tight junctions (TJs) are composed of different 
transmembrane proteins, including occludin and members of the claudin family. Claudins 
are small (20–27 kDa) transmembrane proteins, which support the epithelial barrier 
function and also form paracellular channels (Anderson and Van Itallie, 1995).  Although 
native CP TJs expresses claudin-2, there is no proof for a paracellular pathway for water 
transport in CP epithelia. Moreover, although CP is often considered a “leaky” 
epithelium, there is no solid proof for this assertion (Damkier et al., 2013). On the 
contrary, given its role in the formation of the BCSFB, the CP is expected to be a “tight” 
epithelium, i.e. it must have a transepithelial resistance well above 100 ohm-cm2 
(Friedman, 2008). However, no reliable measurements of transepithelial resistance exist 
for mammalian CP, except for those in cultured monolayers, which range between 150 
and 1,500 ohm-cm2 depending on presence or absence of serum (Hakvoort et al., 1998; 
Angelow and Galla, 2005).  
Since water flows across CPECs from the basolateral through the apical 
membrane, there must be one or more water pathways in both apical and basolateral 
membranes. There are three possible pathways for water permeation across cell 
membranes: 1) AQPs (Papadopoulos and Verkman, 2013), 2) cotransporters (Hamann et 





Krylov et al., 2001). There is evidence for water transport through cation-coupled 
chloride cotransporters like NKCC1 and K+-Cl- (KCCs) (Zeuthen, 1994; Hamann et al., 
2005). However, in the CP these cotransporters mediate vectorial water transport in the 
direction opposite to that expected for net trans-epithelial water movement (Fig.1). There 
is substantial evidence for AQP1 expression in the apical membrane of CPECs (Nielsen 
et al., 1993; Damkier et al., 2013). However, it is debatable whether AQP1 is also 
expressed in the basolateral membrane (Johansson et al., 2005; Praetorius and Nielsen, 
2006; Papadopoulos and Verkman, 2013). Immunolabeling results from the Alvarez-
Leefmans laboratory, using confocal immunofluorescence, demonstrate that AQP1 is not 
expressed in the basolateral membrane (Cha et al., 2014), an observation that is in 
agreement with the original immunogold electron microcopy results of Agre’s group 
(Nielsen et al., 1993). Interestingly, CSF production is reduced only by 25% in AQP1-/- 
mice (Oshio et al., 2003, 2005). This suggests that AQP1 is not the only apical water 
pathway underlying CSF secretion, and the water pathways for water influx across 
basolateral membranes of CPECs are unknown. Likewise, whether AQPs other than 








































Figure1. Transcellular pathways for water transport across choroid plexus epithelial cells. Unlike all 
secretory epithelial cells, CPECs co-express NKCC1 (Na+, K+, 2Cl- cotransporter 1) and Na+/K+ ATPase in 
the apical membrane, together with AQP1. The pathways for water influx in the basolateral membrane are 
unknown (AQPx in the basolateral membrane). It is not understood how transcellular water movement 
occurs through and from the basolateral through the apical side. Further, there might be other AQPs beside 




Previous research from the Alvarez-Leefmans lab using RT-PCR demonstrated 
the existence of transcripts for several AQPs in whole choroid plexus tissue. Specifically, 
mRNAs for AQP water channels 0, 1, 2, 4, aqua-glyceroporins 3, 7, 9, and “unorthodox” 
AQP11 were detected. Transcripts for AQPs 5, 6, 8, and 12 were undetectable (Cha et al., 
2014). 
The global aim of this project is to search for the cellular and subcellular 





et al., 2014). The present work is focused on the cellular and subcellular localization of 
AQPs 4, 7 and 9 using immunolabeling methods with validated antibodies and confocal 
immunofluorescence microscopy. 
 
Choroid Plexus Epithelium Structure and Function 
As mentioned above, the choroid plexuses are branched and highly vascularized 
epithelial structures derived from the ependymal cells lining the brain ventricles 
(Damkier et al., 2013, Barry et al., 2014). There are four choroid plexuses inside the 
ventricular system of the brain; one in each of the two lateral ventricles, one in the third, 
and one in the fourth ventricle (Fig.2A). The choroid plexuses are composed of a 
capillary enveloped by a layer of differentiated ependymal epithelium (Fig. 3). This 
monolayer of epithelial cells that are joined by tight junctions, make up the BCSFB 
(Smith et al., 2004). In humans, the CP secretes about 600 ml of CSF in 24 hours, a rate 
that is similar to that of renal proximal tubules (Damkier et al., 2013). Further, the blood 
flow in CP vasculature is about 5 times greater than that of kidney (Damkier et al., 2013). 
Since the total volume of CSF is about 150 ml, this fluid is replaced approximately 4 
times a day. In addition to CSF production, the CP acts as a filtration system, removing 
metabolic waste, foreign substances, and neurotransmitters from CSF. The kidneys 
remove waste material from blood to urine; whereas, the CPECs remove waste materials 
from CSF to blood. Therefore, the CP has been considered as “the kidney of brain” 
(Spector and Johanson, 1989). In sum, the CP has a crucial role in maintaining the 
composition of the brain extracellular environment required for proper brain function. 
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crucial for CSF circulation (Jimenez et al., 2014). Ependymal cells are loosely connected 
by intercellular adhesion sites known as desmosomes, or adherens junctions thereby 
forming an epithelial sheet that constitutes the lining of the ventricles. Unlike CPECs, 
mammalian ependymal cells do not have tight junctions (Peters and Swan, 1979; Jimenez 
et al., 2014). This may explain why ependymal cells do not form a diffusion barrier 
between brain parenchyma and CSF and thus, brain interstitial fluid composition 
determines and is determined by CSF composition as illustrated in Fig. 2B. Specifically, 
the ependyma is permeable to ions, water and even proteins (Jimenez et al., 2014). 
Indeed, several studies demonstrate that the intercellular spaces between ependymal cells 
allow the passage of water, ions and proteins. For instance, the ependymal intercellular 
spaces are permeable to lanthanum, peptides and proteins such as horse radish peroxidase 
and ferritin that have molecular mass of 43 and 560 kda respectively (Brightman, 1965; 
Cifuentes et al., 1992). 
 Diffusion of CSF usually occurs from brain ventricles into the brain parenchyma 
through these loosely bound junctions between the ependymal cells. (Hladky and 
Barrand, 2014). In contrast, CPECs are modified ependymal cells joined by tight 
junctions which prevents “leakage” of fluid from blood vessels into CSF. Early studies 
suggested a role of ventricular ependymocytes in the secretion of CSF (Pollay and Curl, 
1967). Furthermore, it was reported that CSF production was reduced but not completely 
eliminated by choroid plexectomy (Milhorat et al., 1971). However, this is controversial 
inasmuch as the there are no mechanistic models of how CSF could be secreted by 
ependymal cells, and there is no proof that choroid plexotomy is complete. Thus, it is 
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Figure 4. Radial glial cells and their development. Neuropepithelial (NEP) cells proliferate and give rise 
to neuroblasts, which differentiate into neurons. NEP cells also give rise to radial glia which can contribute 
to neurogenesis directly or via neuronal precursor cells (nIPC), and also differentiate into astrocytes and 
oligodendrocytes. Radial glial can also differentiate into ependymal cells, which in turn are modified to 
form choroid plexus epithelial cells. (Reproduced from Barry, D. S., Pakan, J. M., & McDermott, K. W. 
2014, Barry et al., 2014) 
 
 
Mechanisms of CSF secretion 
CSF is mostly formed inside the cerebral ventricular system. Choroid plexuses 
epithelial cells are known to be the main if not the only source of CSF production (Dandy 
1919; Segal, 1993; Johanson et al., 2008; Chikly and Quaghebeur, 2013). Extrachoroidal 
CSF sources, such as the ependymal cells (Pollay and Curl, 1967; Milhorat et al., 1971) 
or the BBB capillaries (Abbott, 2004) have also been proposed but this is debatable. The 
endothelium of the choroid plexus capillaries is fenestrated, and CSF formation is 
determined by the passage of a plasma ultrafiltrate through the endothelium, which is 
facilitated by hydrostatic pressure. The choroidal epithelium secretes fluid, into the 
ventricles. The passage of solute and water through the choroidal epithelium is an active 
metabolic process which transforms the ultrafiltrate into a secretion (cerebrospinal fluid) 
(Brown et al., 2004). Fluid secretion in choroid plexus epithelia has been found to be 
dependent on the unidirectional transport of ions, which creates osmotic gradient for the 
movement of water (Fig. 5). There are no known pathways for water transport across 
CPECs through basolateral membrane. The basic understanding of this process is 
incomplete and still speculative (Damkier et al., 2013). Thus, one of the goals of this 
project was to provide insight into the mechanisms and pathways underlying net water 






Figure 5. Diagram illustrating the direction of net flux of ions and water across choroid plexus 
epithelial cells. The net flux of Na+, Cl-, HCO3-, and water are in the direction from blood to cerebrospinal 
fluid (CSF). outwards into the lumen, that is coming from the fenestrated capillaries; and the net flux of K+ 
is inwards back into the circulatory system (Courtesy of Dr. Alvarez-Leefmans, 2015). 
 
 
Pathways for water permeation across epithelial cells 
The net transepithelial water transport can occur through transcellular and 
paracellular routes. Accordingly, the net water movement occurs from the basolateral 
through the apical membrane of CPECs. As already mentioned, water permeation across 
cell membranes occur through three pathways: aquaporin channels (AQPs), some 
cotransporters, and to a lesser extent through the membrane lipid bilayer. The intrinsic 
water permeability of lipid bilayers is too low to explain the high volumes of CSF 





fluid secretion rates must occur through aquaporins. Cotransporters cannot explain water 
flux across CPECs because they transport ions (and possibly water) in the direction 
opposite to that expected for net water flux (Damkier et al., 2013). Thus, the most 
plausible explanation for such a large amount and rate of fluid secretion is that channel 
proteins with the features of aquaporins must be involved. 
The role of paracellular pathways in transepithelial water movement is debatable 
(Fischbarg, 2010). A possible role of claudin-2 as a paracellular channel that mediates 
water transport across the tight junctions in “leaky” epithelia has been suggested (Gunzel 
and Yu, 2013). There is evidence for a paracellular water pathway across claudin-2 tight 
junctions’ as discussed above (Rosenthal et al., 2010).  
 
Aquaporin gene-protein family 
Aquaporins are a family of integral membrane proteins some of which transport 
water across cell membranes in response to osmotic gradients (Papadopoulos et al. 2013). 
Aquaporins and Aquaglyceroporins are monomers of molecular weight of ~26-34 kDa 
that contain six membrane-spanning helical segments and two shorter helical segments 
that do not span the entire membrane (Beitz, 2009; Thomas et al., 2002). These 
monomers consist of six transmembrane helical segments and two short helical segments 
that surround cytoplasmic and extracellular vestibules connected by a narrow aqueous 
pore (Walz et al., 1997; Verkman, 2013; Beitz, 2009) (Fig. 6). AQPs usually form 









Figure 6. Membrane topographical structure of Aquaporin 1. This structure consists of eight 
membrane-embedded helical segments (H1–H8) between the N- and C-terminus. (Reproduced from: 
Verkman et al., 2013) 
 
 
The search for a “water channel” accounting for high water flux across epithelial 
cells, that could not be explained by simple diffusion though lipid bilayers, culminated 
with the discovery in the early 90s of CHP 28 (currently known as AQP1), by Peter Agre 
and his coworkers (Preston et al., 1992; Nielsen et al., 1993). CHIP 28 (Channel-Forming 
Integral Protein of 28 kDa) was isolated from water permeable segments of the nephron 
and red blood cells. It was found to be an integral membrane protein with a molecular 
mass of ~28 kDa. The discovery of CHIP 28 ended long-standing controversies about the 
existence of membrane water channel proteins.  
To date, thirteen mammalian aquaporins (0-12) have been identified and partially 





proteins can be divided into three categories, depending on their functional properties 
such as water permeation and selectivity: i) those selectively permeable to water 
(aquaporins); ii) those permeated by water and few other polar molecules like glycerol 
(aquaglyceroporins), and iii) those whose functions are unknown and are currently being 
elucidated, here referred to as unorthodox (Xu et al., 2010) (Fig.7). The mammalian 
Aquaporins consist of AQP0, AQP1, AQP2, AQP4 and AQP5 function primarily as 
water-selective channels. Cells expressing AQP water channels in their plasma 
membrane have ~5- to 50-fold higher osmotic water permeability than membranes which 
do not have AQPs (Verkman and Mitra, 2000). AQP3, AQP7, AQP10 and AQP9 are the 
aquaglyceroporins; they transport water, glycerol, and, in the case of AQP9 they also 
transport other small polar solutes, including amino acids, sugars and arsenite (Verkman, 
2011). AQP6, AQP8, AQP11 and AQP12 are classified as “unorthodox” aquaporins, as 
their functional characteristics are little known or unknown (Xu et al., 2010). 
Furthermore AQPs have also been reported to transport other small molecules and gases, 
including carbon dioxide, ammonia, nitric oxide and hydrogen peroxide (Musa-Aziz et 
al., 2009; Miller et al., 2010). The present work focuses on AQP 4, 7 and 9, thus the 

















Figure 7. Mammalian Aquaporin Family. The aquaporin gene family leads to proteins that are generally 
permeated only by water (AQP0, AQP1, AQP2, AQP4, AQP, 5). The aquaglyceroporins are permeated by 
water and small solutes such as glycerol (AQP7, AQP3, AQP9, AQP10). The unorthodox (AQP11, 
AQP12, AQP8, AQP6) are members with little known functions. AQP10 is a pseudogene in mice. 




Aquaporin 4 (AQP4) is a transmembrane protein which functions as molecular 
water channel. It is also known as the “mercurial-insensitive water channel” (MIWC) 
(Yang and Verkman, 1996). Its cloning from lung and brain was described in 1994 by 





We chose to investigate the expression of AQP4 in choroid plexus epithelium and in 
ependymal cells because of its potential functional implications in CSF secretion and 
brain water homeostasis. Another strong reason that motivated the search for AQP4 
expression in CP is its abundant mRNA expression, as evidenced from RT-PCR work 
from the lab, on mouse whole choroid plexus (Cha et al, 2014), and from reports in the 
literature showing its expression in CPECs using in situ hybridization (Venero et al., 
1999), immunolabeling (Mobasheri et al., 2007; Speake et al., 2003), and immunoblots 
(Nazari et al., 2014). Specifically, the in situ hybridization results of Venero’s group 
(Venero et al., 1999) reported a strong hybridization signal of AQP4 mRNA in the 
choroid plexus of the lateral ventricles.  However, the expression of AQP4 in CPECs has 
been studied by other investigators showing that the AQP4 mRNA is not expressed in 
CPECs. Accordingly, using in situ hybridization two independent groups were unable to 
detect AQP4 hybridization signal in CP (Hasegawa et al., 1994; Jung et al., 1994). Using 
immunoperoxidase with affinity purified antibodies (Frigeri et al., 1995) demonstrated 
AQP4 (MIWC) immunoreactivity in rat astrocytes and ependyma, but CPECs were not 
immunoreactive. Similarly, Soren Nielsen’s group using immunogold EM was unable to 
demonstrate AQP4 immunoreactivity in CPECs (Nielsen et al., 1997).   
The immunolabeling studies purporting the expression of AQP4 in CPECs 
deserve further comment. None of the three studies reporting AQP4 expression in CPECs 
(Mobasheri et al., 2007; Speake et al., 2003; Nazari et al., 2014) were done with 
antibodies validated against AQP4 -/- animals. The studies by Speake (Speake et al., 
2003) and Mobasheri (Mobasheri et al., 2007) showed a diffuse cytoplasmic pattern of 





“densely packed in the cytoplasm” of CPECs with no expression in the membrane 
(Nazari et al., 2014). However, the latter authors did not show these results. From the 
above data it can be concluded that the expression of AQP4 in CPECs cells is 
controversial. The present study specifically addresses this issue to solve this 
controversy. 
As for the case of ependymal cells, using in situ hybridization, AQP4 mRNA 
expression has been reported by Hasegawa and Jung (Hasegawa et al., 1994; Jung et al., 
1994) in the ependymal cells lining various brain areas. However, it is not clear from the 
images published by these authors to determine if the observed hybridization signal is in 
the ependymal cells or in surrounding cellular elements such as the multiple glial ending 
process that exist in between and in the basal region of ependymal cells. A similar 
conclusion can be reached by examining the first paper reporting AQP4 expression in the 
ependyma. These authors found that AQP4 (then named MIWC) was “strongly expressed 
in the ependymal layer lining the aqueductual system” (Frigeri et al 1995). However, 
since they did not use glial markers it is not possible to ascertain whether the 
immunoreactivity was localized to the ependymal cells or to the surrounding glial 
membranes. Immunolabeling studies using peroxidase immunoreactivity and 
immunogold-EM showed that subpopulations of ependymal cells, specifically those 
covering the subfornical organs and other osmosensory areas, expressed AQP4 in the 
basolateral membrane of ependymocytes (Nielsen et al., 1997).  The authors cautiously 
stated that they found “moderate densities of gold particles in the basolateral membranes 
of the ependymal cells covering the subfornical organ,” whereas the apical membranes 





membranes that are in direct contact with capillaries and the pia mater. Other studies 
(Roales-Bujan et al., 2012; Jimenez et al., 2014) using immunolabeling with non-
validated AQP4 antibodies claim that AQP4 is expressed in the apical and basolateral 
membranes of mouse lateral ventricle ependymal cells. Thus, whether AQP4 is expressed 
in ependymal cells other than those in the subfornical organ is debatable. The issue of 
whether AQP4 is expressed in ependymocytes and/or surrounding glial membranes is 
specifically addressed in the present study using multiple immunolabeling with glial 
markers.    
 
Localization of AQP4 in other cell types  
Unlike the debatable expression of AQP4 in CPECs and EPCs discussed above, 
there is overwhelming evidence for AQP4 expression in astrocytes (Frigeri et al., 1995; 
Nielsen et al., 1997; Rash et al., 1998; Nagelhus et al., 2004), using antibodies validated 
against KO tissues (Katada et al., 2014). Expression of AQP4 is very prominent in 
astroglial endfeet, particularly at perivascular glial processes, subpial membranes and the 
ventricular surface (Nielsen et al., 1997; Nagelhus et al., 2004).  
In extracerebral tissues, AQP 4 is expressed in kidney, skeletal muscle, salivary 
and lacrimal glands (Frigeri et al., 1995). In rat kidney AQP4 was found mainly in the 
proximal tubules of the inner medullary collecting ducts (IMCD).  Immunoelectron 
microscopy demonstrated AQP4 labeling of the basolateral membrane of IMCD cells, 
with relatively little labeling of intracellular vesicles (Terris et al., 1995). Using AQP4 
antibodies validated against AQP4-/- tissues, Van Hoek (Van Hoek et al., 2000) 





segments in mouse kidney. Also, AQP4 is highly expressed in the sarcolemma of skeletal 
muscle fibers (Frigeri et al., 1995; Crosbie et al., 2002; yang et al., 2000). These tissues 
(skeletal muscle and kidney) were used in present work as positive controls.  
 
Aquaporin 7 
Aquaporin 7 (AQP7), another member of the AQP gene family, is a 
transmembrane protein permeable to water, glycerol and urea and therefore it is an 
aquaglyceroporin. AQP7 was first cloned from rat testis by Ishibashi’s group (Ishibashi et 
al., 1997). This 26-KDa protein was functionally characterized by the same group using 
heterologous expression in Xenopus oocytes. Osmotic water permeability across oocytes 
membrane was increased by 10-fold with respect to uninjected oocytes. Another 
significant feature is that the osmotic water flux through AQP7 was not inhibited by 0.3 
mM mercury chloride. 
We decided to investigate the protein expression of AQP7 in CPECs and EPCs 
because of its abundant mRNA expression in whole CP tissue (Cha et al., 2014), and 
because little is known about the expression of this protein in CPECs and EPCs where it 
may play a role in water transport together with AQP1. There is only one published study 
showing diffuse AQP 7 immunoreactivity in both CPECs and EPCs, but its subcellular 
localization i.e. apical or basolateral membrane on CPECs and/or EPCs was not 
investigated (Shin et al., 2006). In their study, Shin’s group used a well characterized  
polyclonal antibody (sc-28625, SC), which is the same used in the present work and 
which has been validated in several studies (Laforenza et al., 2010, 2013; Goubau et al., 





(Fruhbeck, 2005, 2006; Maeda et al., 2008, 2009) and in endothelial cells within human 
adipose tissue. (Rodriguez et al., 2011; Laforenza et al., 2013). AQP7 has significant 
influence on glycerol metabolism by facilitating glycerol transport between adipocytes 
and blood (Lebeck, 2014). AQP7 KO mice are obese (Hara-Chikuma et al., 2005). The 
lack of AQP7 results in an increased accumulation of glycerol within adipocytes leading 
to their hypertrophy (Hibuse et al., 2005). 
 
Localization of AQP7 in other cell types 
AQP7 has been found in rat testis by real-time PCR (Sakai et al., 2014). The 
expression of AQP7 has been studied in the testis and sperm. It is highly expressed in 
sperm (Sohara et al., 2007). It is shown in more detail in the rat testis by an 
immunohistochemical method (Suzuki-Toyota et al., 1999). Nejsum and Nielsen group 
(Nejsum et al., 2000) demonstrated the expression of AQP7 protein in rat and mouse 
kidney where it was found to be localized at the apical membrane of the proximal 
tubules. Also, AQP7 is highly expressed in mouse sarcolemma of skeletal muscle fibers 
and it has been extensively investigated at mRNA and protein levels (Wakayama et al. 
2004). These tissues (skeletal muscle and kidney) were used as positive controls in 
present study.  
 
Aquaporin 9 
Aquaporin 9 (AQP9), another member of the aquaglyceroporin subfamily is a 
transmembrane protein that allows permeation of water, glycerol and urea. It was first 





(Ishibashi et al., 1998). This 31.4-KDa protein was functionally characterized by the 
same group using heterologous expression in Xenopus oocytes. Osmotic water 
permeability of oocytes membrane was increased by 7-fold with respect to uninjected 
oocytes, and it was inhibited by 0.3 mM mercury chloride. We investigated the protein 
expression of AQP9 in CPECs and EPCs because of its abundant mRNA expression in 
whole CP tissue (Cha et al., 2014), and because its possible expression in choroid plexus 
has not been studied. Further, AQP9 expression in ependymal cells and astrocytes is 
controversial (see below).  
Using double immunolabeling with anti-GFAP, Badaut’s group (Badaut et al., 
2004) found expression of AQP9 in astrocytes and glia limitans. AQP9 labeling was clear 
in astrocytic processes and their cell bodies. Badaut’s group used a well characterized 
rabbit polyclonal antibody (AQP91-A, alpha), which is the same used in the present 
study. This antibody has been validated against AQP9 KO mouse tissues (Mylonakou et 
al., 2009).   
AQP9 transports glycerol and highly expressed in liver cells, where it serves as 
the main glycerol channel. AQP9 abundance changes in parallel with alterations in the 
glycerol permeability of hepatocytes (Calamita et al., 2012). It has been reported that 
AQP9 plays a pivotal role in supplying glycerol for gluconeogenesis (Jelen et al., 2011). 
There are conflicting reports about AQP9 expression in ciliated ependymal cells 
and astrocytes (Albertini and Bianchi, 2010). AQP9 immunolabeling was found to be 
associated with cells, surrounding the cerebral ventricles, including ependymal cells and 
tanycytes in the hypothalamus (Elkjaer et al., 2000). In the same study they were unable 





2000). On the other hand, Badaut’s group reported astrocytic AQP9 expression in the 
mouse brain (Badaut et al., 2001), but they did not find ependymal immunostaining. 
AQP9 was found to be expressed in different subsets of glial cells in the adult forebrain 
periventricular region and in the ependymal and subependymal layer co-expressed with 
GFAP (Cavazzin et al., 2006). Clearly, the expression of AQP9 in ependymal cells and 
astrocytes is debatable (Albertini and Bianchi, 2010). The issue of whether AQP9 is 
expressed in ependymocytes and/or surrounding (subependymal) glial membranes is 
specifically addressed in the present study using multiple immunolabeling with glial 
markers. 
 
Localization of AQP9 in other cell types 
Using real time PCR, AQP9 mRNA was found in rat liver, brain and testis, but it 
was absent in kidney (Sakai et al., 2014). AQP9 mRNA was also detected in mouse liver 
cells (Kuriyama et al., 2002). AQP9 protein expression in mouse liver bile ducts and 
testis were ascertained by immunolabeling (Nicchia et al., 2002). Badaut (Badaut at al., 
2004) also reported the presence of AQP9-IR in mouse liver, whereas no AQP9-IR was 














The high rate of CSF secretion via CPECs cannot be easily explained by the 
presence of a single apical aquaporin such as AQP1. This assertion is supported by 
experiments showing that CSF secretion rate is reduced by only 25% in AQP1 KO mouse 
(Oshio et al., 2003). If transcellular water transport underlies CSF secretion, there must 
be other AQPs in CPECs besides apical AQP1.  
We hypothesize that there are AQPs other than AQP1 localized to the apical 
membrane and to the basolateral membrane of CPECs explaining the water flux across 
CP.  We also hypothesize that ependymal cells, which are the precursors of CPECs, 
already express some of the proteins of CPECs. These hypotheses began to be tested in 
previous work in the lab using RT-PCR with primers designed to amplify transcripts for 
all AQPs. Gene profiling of all known mRNAs of the AQP gene family in mouse CP 
showed that besides AQP1, whole CP tissue expresses transcripts for AQPs 0, 2, 3, 4, 7, 9 
& 11.  
 
Overall Aim 
To investigate the cellular and subcellular localization of AQP proteins in CPECs 







The Specific Aim of the present work 
To determine the cellular and subcellular localization of AQP4, AQP7, and AQP9 




















MATERIALS AND METHODS 
 
Animal Use 
All animal experiments were done following the National Institutes of Health 
(NIH) guidelines and were carried out with a protocol approved by the Wright State 
University (WSU) Laboratory Animal Care and Use Committee (LACUC). The 
immunolabeling analysis was performed in tissues obtained from two mouse lines named 
as follows: NKCC1|PV-Cre|GFP| and NKCC1 KO and wild type mice (Mus musculus) 
on mixed background (C57BL/129vJ) and (NKCC1 KO 129jv/BS line breeders) 
respectively.  Five wild type (WT) mice of various postnatal ages were used: P 12 
(NKCC1|PV-Cre|GFP|), P 19 (NKCC1 KO 129jv/BS), P 20 (NKCC1|PV-Cre|GFP|), and 
P 30(2 mice, one from each line). No differences were found in AQP4, 7 and 9 
expressions between WTs irrespective of their background and postnatal age. In addition 
we used two P29 NKCC1 knockouts (NKCC1|PV-Cre|GFP|) to validate anti-NKCC1 
antibody. Surgical procedures like non-survival surgery and perfusion were performed in 
the Microscope Core Facility (MCF) at Wright State University. 
 
Perfusion Method 
Mouse tissues were obtained from anesthetized (Euthasol 0.1ml/10g, 





M phosphate buffer with 0.8% NaCl, 0.025% KCl, and 0.05% NaHCO3, pH 7.4), 
followed by room temperature fixative (4% paraformaldehyde in 0.2 M of phosphate 
buffer, pH 7.4). Brain, kidney, liver and skeletal muscle tissues were quickly removed 
and post fixed in the same fixative for 2 hours, at 4OC.Then, the tissues were stored 
overnight at  4°C in a 15% sucrose solution in 0.1M phosphate buffer for cryoprotection. 
Before sectioning tissues were immersed in OCT compound Tissue-Tek® 4583 (Electron 
Microscopy Sciences, Hattfield, PA) and mounted on Cryomold® Molds in Adapters 
Sakura® Finetek (Sakura Finetec USA INC). Coronal, sagittal or transverse sections 10 
µm thickness were cut on a cryostat and mounted on VWR Micro Slides (VWR North 
America Cat. No.48312-003). Slides could be stored for months at 4oC. 
 
Antibodies for immunocytochemistry 
 
Immunolabeling of AQP4  
Slides with sections mounted were rinsed with PBS-T (0.01 M PBS containing 
0.1% Triton-X, pH 7.3) three times for five minutes each, blocked with normal goat 
serum (10% in PBS) for one hour, and then incubated with primary antibody, overnight, 
at 4OC. To label AQP4 we used rabbit polyclonal antibody raised against amino acids 
244-323 mapping at the C-terminus of AQP4 of human origin (H-80; sc-20812, Santa 
Cruz Biotecnology, Inc, Dallas, TX). After several dilution tests, 1:50 dilution was 
chosen because it gave the clearest results (see table1). The slides were then washed in 





rabbit secondary antibody for 45 minutes at room temperature. The secondary antibody 
(Alexa Fluor 594-conjugated, affinity purified  goat anti-rabbit IgG (Jackson 
ImmunoResearch, West Grove, PA) was used at a 1:200 dilution. After incubation with 
secondary antibody, the sections were washed again with 0.01M phosphate buffer (three 
times for five minutes each), before mounting them in ProLong Gold antifade reagent 
with DAPI (Molecular Probes, Life technologies, Ref # P36931). The sections were 
initially visualized and photographed with an Olympus BX51TF epifluorescence 
microscope with an attached Spot RT Color camera. Selected sections were visualized 
and photographed with an Olympus Fluoview, FV1000 confocal microscope. 
 The specificity of the antibody raised against AQP4 used in this work has been 
tested in AQP4 KO mouse tissues (Katada et al., 2014), and by Western blotting 
(Benfenati et al., 2007). Further, for positive controls for antibody specificity tissues were 
selected in which AQP4 transcript  (Sakai et al., 2014; Mobasheri et al., 2007) and protein 
have been demonstrated. Thus, positive controls consisted of immunolabeling of 
basolateral membranes of proximal tubule S3 segments in mouse kidney (Van-Hoek et 
al., 2000) and mouse skeletal muscle (Frigeri et al., 2004), as shown in Figs. 13B and D. 





















Figure 8. Control of AQP4 immunolabeling 
in the absence of primary antibody, in 
mouse kidney cortex. Proximal convoluted 
tubules and some cortical collecting ducts of 
mouse kidney were exposed to secondary 
antibody goat anti-rabbit conjugated to 
AlexaF-594, without primary antibody. Image 
obtained from RT-spot camera attached to 
epifluorescence microscope using a 20X 
objective. Scale bar represents 20 µm. 
Background fluorescence (red). Nuclei were 
stained with DAPI (blue).This image shows 
that the background fluorescence was minimal 
and distinctly different from that using 




Triple immunolabeling of AQP4, NKCC1 and DAPI  
       Triple immunolabelling of AQP4, NKCC1 and cell nuclei (DAPI) was done 
by sequential immunostaining following a method similar to that described by Wahlby et 
al. (2002). First, the slides were rinsed with PBS-T (0.01 M PBS containing 0.1% Triton-
X, pH7.3) three times for five minutes each, blocked with normal goat serum (10% in 
PBS; Sigma-Aldrich G 9023) for one hour, and then incubated overnight, at 4oC with 
primary anti-AQP4 rabbit polyclonal Ab (H-80; sc-20812). The second day, sections 
were washed with 0.1M phosphate buffer three times for five minutes each, and 
incubated with goat anti rabbit secondary Ab (Alexa Fluor 594-conjugated goat anti-
rabbit IgG; 1:200, Jackson) for 45 minutes at room temperature. After incubation with 
secondary antibodies the sections were washed again with 0.01M phosphate buffer three 





i.e. anti-NKCC1 (N-16; sc-21545, affinity purified goat polyclonal antibody raised 
against the N-terminus of hNKCC1). Sections were blocked with normal horse serum 
(10% in PBS; Life Technologies Cat# 16050-122) for one hour, and then incubated in 
anti-NKCC1 antibody (1:2000) overnight at 4OC. The third day, the sections were 
washed with 0.1M phosphate buffer three times for five minutes each and incubated with 
donkey anti rabbit secondary antibody (Alexa Fluor 488-conjugated AffiniPure goat anti-
rabbit IgG, 1:200, Jackson) for 45 minutes at room temperature. After incubation with 
secondary antibody, the sections were washed again with 0.01M phosphate buffer three 
times for five minutes each before incubation with Prolong Gold antifade reagent with 
DAPI (Molecular Probes, Life technologies), overnight at room temperature. All 
overnight labelling was done by covering the slides with a cardboard box. The specificity 
of the antibody used in this work against NKCC1 was tested on NKCC1 KO mice 
choroid plexus sections (Fig.9), where this protein is expressed in the apical membrane 




Figure 9. NKCC1 antibody specificity 
test in choroid plexus epithelial cells 
of lateral ventricle of NKCC1 KO 
mouse brain. Image shows lack of 
NKCC1 immunoreactivity. Nuclei 
stained with DAPI. NKCC1-Ab 
(1:1000). Secondary antibody donkey 
anti-goat conjugated to AlexaF-488. 
Green background fluorescence can be 
observed. Image from RT-spot camera; 
20X objective; scale bar 20 µm. This 
image should be compared to those in 





Quadruplet immunolabeling of AQP4, NKCC1, GFAP and DAPI 
Quadruplet immunolabeling studies were performed by the sequential 
immunostaining method described above, by treating the sections with antibodies in the 
following order: AQP4 Ab, NKCC1 Ab, Glial fibrillary acidic protein (GFAP) Ab and 
DAPI. Immunolabeling with AQP4 and NKCC1 Abs was exactly as described for triple 
immunolabeling. The third day Sections were blocked with normal rabbit serum (10% in 
PBS) for one hour, and then incubated with anti-GFAP antibody overnight at 4OC. The 
anti-GFAP (ab4674) affinity purified chicken polyclonal antibody was used at 1:2000 
dilutions. The fourth day, the sections were washed in 0.1M phosphate buffer three times 
for five minutes each and incubated at room temperature, during 45 minutes, with 
secondary antibodies conjugated to DyLight-649 (rabbit anti-chicken IgG; 1:200, Jackson 
ImmunoResearch, West Grove, PA). The sections were washed again with 0.01M 
phosphate buffer three times for five minutes each before mounting applying Prolong 
Gold antifade reagent with DAPI (Molecular Probes, Life technologies) overnight. The 
specificity of the GFAP Ab used in this study as a glial marker has been validated by 
Western blotting (Lonskaya et al., 2013) and numerous immunolabeling studies including 
astrocytes and radial glial cells (Takano et al., 2006; Achuta et al., 2014). 
 
Immunolabeling of AQP7  
The procedure for immunolabeling AQP7 channels was same as described before 
for AQP4. AQP7 channel immunoreactivity was localized with anti-AQP7 (R-101; sc-





terminus of AQP7 of rat origin (Table 1). For AQP7 we used the same blocking serum 
and secondary antibody used for AQP4. The specificity of the AQP7 antibody used in 
this work has been tested by preadsorption (Laforenza et al., 2010). Positive controls 
included detection of immunoreactivity in apical membrane of proximal tubules of mouse 
kidney (Nejsum et al., 2000) and mouse skeletal muscles (Wakayama et al., 2004), as 
shown in Figs 16B and C. Negative control by omitting the primary antibody is shown in 
Fig. 10. Negative control in a tissue that do not express AQP7 i.e. mouse liver, is shown 







Figure 10. Negative control of AQP7 
immunolabeling in the absence of primary 
antibody in mouse kidney cortex. Proximal 
tubules of mouse kidney treated with 
secondary antibody goat anti-rabbit 
conjugated to AlexaF-594. This image from a 
P30 WT mouse shows slight red background 
fluorescence, which is very different to that 
observed when the primary antibody is present 
as shown in Fig. 16B. Image obtained from 
RT-spot camera microscope. 40X objective. 
Scale bar is 10 µm. Nuclei stained with DAPI 


















Figure 11. Negative control of AQP7 
antibody in mouse liver cells.  A high 
concentration of AQP primary Ab (1:10) and 
secondary antibody goat anti-rabbit 
conjugated to AlexaF-594 (1:200) did not 
produce IR in liver, which is known to be a 
tissue where AQ7 is not expressed (Sakai et 
al, 2014). Image obtained using RT-spot 
camera. 20X objective; scale bar 20 µm 
exhibiting slight background fluorescence 




Immunolabeling of AQP9  
The procedure for immunolabeling AQP9 channels was basically the same as that 
described for AQP4 and AQP7. AQP9 immunoreactivity was localized with anti-AQP9 
(AQP91-A) rabbit polyclonal antibody raised against 18 amino acids mapping at the C-
terminus of rat AQP9 (Table 1).The same blocking serum and secondary antibody used 
for AQP4 and 7 was used for AQP9. The specificity of the antibody has been tested 
against AQP7 KO tissues (Rojek et al., 2007). Positive controls of the antibody consisted 
of quantitative real-time PCR analysis (Sakai et al., 2014) and immunoreactivity in liver 
cells (Elkjaer et al., 2000) (see figure of results obtained). Negative Control consisted of 
staining in kidney cells with known no AQP9 expression (Ishibashi et al., 1998) (Fig. 12). 





method with AQP9 antibody, GFAP antibody and nuclei stained with DAPI in same 
procedure described before for AQP4 triple immunolabeling.  
 
 
Figure 12. Negative control of AQP9 
antibody in mouse kidney. AQP 9mRNA is 
not expressed in mouse kidney (Sakai et al, 
2014). Thus this tissue has been used a control 
for immunocytochemistry (Badaut et al, 2001, 
Nielsen et al, 2001). In this section of 
proximal tubule cells of mouse kidney were 
immunostained using AQP9 antibody (1:500). 
Secondary antibody was goat anti-rabbit 
conjugated to AlexaF-594.  Image obtained 
from RT-Spot camera attached to 
epifluorescence microscope. Objective 20X. 
Scale 20 µm. Note background fluorescence 




Epifluorescence microscopy and confocal imaging 
Images were initially obtained on an Olympus Epi-fluorescence Spot scope with 
an RT color camera. The epifluorescence microscope (Olympus BX51) attached to the 
Spot camera was equipped with the following objectives, all of which were used at 
various stages of this work: 4X objective (NA 0.16), 10X objective (NA 0.26), 20X 
objective (NA 0.75) and 60X oil immersion (NA 1.35). Confocal images were obtained 
from a Fluoview 1000 Olympus microscope, using a 60X (NA 1.35) oil immersion 
objective at 0.25 µm Z-steps. Molecular labels were excited using the following laser 





Confocal optical sections were collected and analyzed using Fluoview software. Stacks 
from confocal images were generated using ImageJ software (imagej.nih.gov/ij), using 
TIFF images exported from Fluoview Software. Images were added to the “stack” option 
in the main toolbar of Image J software. The only image stacks shown in this work are in 






















Table1. Primary Antibodies used in the present study 
         
           PRIMARY 
         ANTIBODY 
    HOST  
    TYPE 
        SOURCE TESTED 
AGAINST 
KO MOUSE 
DILUTION   
 
        Anti-AQP4 
          (H-80) 
           sc-20812 
 
 









       1:50 
             Anti-AQP7 
           (R-101) 
            sc-28625 
 
   Rabbit 
Polyclonal 
Santa Cruz     
Biotechnology,
Inc. 
           No                   1:50 
            Anti-AQP9 
            (AQP91-A) 





           Yes            1:500 & 1:200 
             AntiNKCC1 
             (N-16) 
               sc-21545 
 
              Anti-GFAP    
                 (ab4674) 
 
    Goat  
 Polyclonal 











         No 




         1:2000 














Localization of Aquaporin 4 in mouse choroid plexus epithelium and ependymal cells  
Immunolabeling methods with validated antibodies and confocal 
immunofluorescence were used to determine the cellular localization of AQP4 within the 
choroid plexus epithelium and ependymal cells. AQP4 was not found in the choroid 
plexus (CP) but in the epedymal region (EP) lining the lateral ventricles. The AQP4-IR in 
EP was found in the basal aspect of the ependymal cells, and in finger-like structures in 
between the EP cells. These AQP4-immunoreactive structures having calyx-like shape, 
surounding the basolateral aspects of  EPCs are shown at higher maginification in Fig. 
13D (arrowheads). AQP4-IR was also prominent in structures surrounding capillaries as 
shown in Fig. 13A (CAP). As positive controls for antibody specificity we used kidney 
proximal tubules (Fig. 13B) and skeletal muscle sarcolemma (Fig. 13C). AQP4 
expression in the basolateral membrane of proximal kidney tubules is well established 
both in both mouse (Van-Hoek et al., 2000) and rat (Huang et al., 2001). Similarly, AQP4 








Figure 13.  Aquaporin 4 water channel protein (AQP 4) immunolabeling in mouse (P-30) lateral 
brain ventricle structures, kidney proximal tubules and skeletal muscle fibers.  A) Micrograph of a 
confocal optical section (0.25 µm) of the lateral ventricle (LV) showing AQP4 immunoreactivity (IR) in 
ependyma (EP) and surrounding an arteriolar capillary (CAP). Note that the choroid plexus (CP) does not 
show AQP4-IR. Strong AQP4-IR is found in the basal aspect of ependymal cells, and in between these 
cells.  The framed area in A is shown at higher magnification in D, where arrowheads indicate the AQP4 
immunoreactive structures, which appeared encroaching the ependymal cells. B) Non-confocal 
immunolabeling of kidney proximal tubules showing basolateral AQP4 location (arrows). C) Non-confocal 
immunofluorescence of hind limb skeletal muscle fibers where AQP4-IR is evident in the sarcolemma. 
AQP4-IR is shown in red (Alexa F 594 secondary Ab, primary anti-AQP 4 polyclonal Ab sc-20812). 
Nuclei stained with DAPI (blue). A 60X oil objective was used to obtain images in A and D. B and C 








Colocalization of AQP4 and NKCC1 in mouse ependyma and capillaries 
 
 
The AQP4-IR shown in the EP (Fig. 13 A and D; Fig. 14D) could be located in 
the basolateral membrane of ependymal cells, or in structures surrounding these cells. To 
investigate this issue, we studied the cellular and subcellular colocalization of AQP4 with 
NKCC1, the Na+,K+, 2Cl- cotransporter known to be expressed in astrocytes (Plotkin et 
al, 1997; Yan et al, 2001, 2001) and in the apical membrane of CPECs  (Plotkin et al., 
1997; Piechotta et al 2002).  As expected,  NKCC1 was found to be expressed in the 
apical membrane of CPECs (Fig. 14 A). NKCC1 was expressed not only in CPECs but in 
the apical membrane of ependymocytes (EP in Fig. 14 A, green and C green). NKCC1 
was also expressed in the basal aspect of the ependymal cells (subependymal zone) where 
it colocalized with AQP4 (Fig. 14 A, yellow, and Fig. 14D yellow). We also found very 
clear colocalization of NKCC1 and AQP4 in structures surrounding capillaries (asterisk 
in Fig. 14A, yellow). These structures most likely represent astrocytes endfeet, since they 
were labelled with GFAP (not shown). Thus, the data confim NKCC1 expression in the 
apical membrane of CPECs and shows for the first time that NKCC1 is also expressed in 
the apical membrane of lateral ventricle ependymal cells. As for the basal location of 
NKCC1 in between  ependymal cells and in their basal aspect in the subependymal zone, 
it was found that this cotransporter colocalized with AQP4. The question arises as to 
whether NKCC1 and AQP4 in the basolateral aspect of ependymal cells were located in 
the endings of radial glial cells known to be present in between ependymal cells and in 





of the EP cells. To investigate this, we used quadruplet immunolabelling of NKCC1, 















Figure 14.  Confocal images of triple immunolabeling of AQP4 (red), NKCC1(green) and DAPI 
(blue) in choroid plexus epithelial cells (CPECs) and ependyma (EP) of lateral ventricle (LV) of 
mouse (P-30) brain. A) NKCC1 immunolabeling (green) in the apical membrane of both CPECs and 
ependymal cells (EP). NKCC1 colocalized with AQP4 (yellow merge) in structures in between ependymal 
cells and in their basal aspect in the subependymal zone. Similarly, NKCC1 and AQP4 were colocalized in 
a subependymal arteriolar capillary. The framed area in A is shown at higher magnification in B, C, and D.  
B) AQP4 (red) immunoreactivity in between ependymal cells and in their basal poles in the subependymal 
zone. Arrowhead shows one intercellular AQP4 immunoreactive structure. Most of these structures 
coexpressed NKCC1, as can be observed in A and D (yellow). C) High magnification NKCC1-IR in the 
apical membrane of CPECS and EP cells. D) Merged image of B and C to show colocalization (yellow) of 
NKCC1 and AQP4. Note that apical NKCC1 in CPECs and EP cells does not colocalize with AQP4. 
NKCC1 and AQP4 colocalized in structures in between ependymal cells and in the subependymal pole of 
these cells. Images were obtained with a 60X Oil Objective at 0.25 um Z-step; scale bars   represent 10 µm. 
AQP4 secondary Ab (red, Alexa F 594), Anti-AQP 4 primary Ab (sc-20812), NKCC1-IR secondary Ab 






Colozalization of AQP4, NKCC1 and GFAP in ependyma and subependymal layers.  
 
To investigate if the structures expressing AQP4 and NKCC1 were glial 
processes, we used quadruplet immunolabeling of sections of mouse brain stained with 
antibodies against AQP4, NKCC1, GFAP and DAPI (Fig. 15). The results confirmed 
strong NKCC1-IR (in blue) in the apical membrane of CPECs, and in the apical domain 
of the ependymal cells (EP) throughout the lining of the lateral ventricles (Fig. 15A, B). 
NKCC1 in CPECs and EP cells was not colocalized with GFAP or AQP4. In contrast, 
NKCC1 expressed in structures surrounding the basolateral aspects of ependymal cells 
colocalized with GFAP, which in the merge images appears in cyan (Fig. 15 A and B, 
arrowheads). The details of the framed area in Fig. 15A are shown in Figs. 15B-D at 
higher magnification. Fig. 15B, shows the co-localization of NKCC1-IR (blue) and 
GFAP-IR (green), which appears in cyan (arrows), suggesting that the subependymal 
structures end processes of radial glia. AQP4 co-localized with GFAP and it is also found 





expression of GFAP-IR (green) and DAPI (white) in the subependymal zone and in 
between EPCs. 
 
Figure 15. Confocal images of quadruplet immunolabeling of NKCC1, AQP4, GFAP and DAPI in 
choroid plexus epithelial cells (CPECs) and ependyma (EP) of lateral ventricles (LV) of mouse (P-30) 
brain. A) NKCC1 (blue) is expressed in the apical membrane of ependymal cells (EP) and in the apical 
membrane of CPECs (CP). NKCC1 in the basal aspect of the EP colocalized with GFAP (green); the merge 
image appears in cyan. The square framed are in A, is shown at higher magnifications in B, C and D. B) 
colocalization of NKCC1 (blue) and GFAP (green) in cyan (arrow heads) in between ependymal cells and 
subependymal layer structures. Note apical NKCC1 in ependymal cell. C) Colocalization (yellow) of 
AQP4 (red) in GFAP (green) immunoreactive structures in the  subependymal zone. D) Expression of glial 
marker GFAP in subependymal structures surrounding the cell bodies of ependymal cells. DAPI in all 
panels is in white. Images are stacks of 4 confocal optical sections (slices Z27-Z30) at 0.25 µm steps in the 
z axis, taken with a 60X oil objective.  Scale bars 10µm.  All Abs as in previous figures, except for GFAP 





Localization of Aquglyceroporin 7 (AQP7) in mouse choroid plexus and ependymal 
cells  
Fig. 16A shows a mouse brain at the level of the lateral ventricle. The section was 
labelled with AQP7 antibody. We have found distinct immunofluorescence restricted to 
the apical membrane of CPECs. AQP7 expression was also found in the apical membrane 
of ependymal cells. As positive control we used mice tissues where AQP7 expression is 
well established i.e.  apical membrane of kidney proximal tubules and skeletal muscle.  A 
clear pattern of AQP7 IR (arrows) is observed in Fig. 16B, the apical membrane of 
proximal convoluted tubules of mouse kidney. Fig 16C, shows strong AQP4-IR (arrows) 























Figure 16.  Aquaporin 7 water channel protein (AQP 7) immunolabeling in mouse (P-30) lateral 
brain ventricle structures, kidney proximal tubules and skeletal muscle fibers.  A) Micrograph of a 
confocal optical stack prepared from slices Z31-Z38, each slice (0.25 µm) of the lateral ventricle (LV) 
showing AQP7 immunoreactivity (IR) in the apical membranes of Choroid plexus (CP) and ependyma 
(EP). B) Non-confocal immunolabeling of kidney proximal tubules showing apical AQP7 localization 
(arrows). C) Non-confocal immunofluorescence of limbs skeletal muscle fibers where AQP7-IR is evident 
in the sarcolemma. AQP7-IR is shown in red (Alexa F 594 secondary Ab, primary anti-AQP 7 polyclonal 
Ab sc-28625). Nuclei stained with DAPI (blue). A confocal 60X oil objective was used to obtain images in 
A. B and C immunofluorescence was visualized with a 20X objective non confocal microscope. Scale bars 
in A, 10 µm; and in B and C, 20 µm. 
 
 
Localization of Aquglyceroporin 9 (AQP9) in mouse choroid plexus and ependymal 
cells  
Fig 17 A, B and C shows mouse brain at the level of thalamus and the auditory 
neocortex. The section was labelled with AQP9 antibody. AQP9 immunofluorescence 
was found absent in CP, but was found restricted in the sub ependymal zone of some 
areas of the lateral ventricle, specifically in the areas surrounding the thalamus and the 
neocortex (Fig. 17 A), where it colocalized with GFAP (Fig. 17 C). AQP9-IR was 
colocalized with GFAP (glial marker) suggesting its glial location. Fig. 17 B shows the 
GFAP-IR in subependyma. As positive control we used mouse tissue where AQP9 
expression is well known and undisputed, like mouse liver cells and glial cells. Fig. 17 D 
shows strong AQP9-IR (arrows) in the apical and few domains of basolateral membrane 
of bile duct of liver. Fig. 17 E, F shows strong AQP9-IR and GFAP-IR between fimbria 
and lining of lateral ventricle The Co-localization of AQP9 and GFAP-IR is in yellow 














Figure 17.  Aquaporin 9 water channel protein (AQP 9) immunolabeling in mouse (P-30) brain 
thalamus, the auditory neocortex and liver bile duct.  A) Non-confocal immunolabeling of AQP9 
showing that there is no AQP9 immunoreactivity (IR) of AQP9 in CPECs and in Ependyma (EP) but strong 
IR (arrows) is observed in the subependymal layer surrounding the thalamus and the auditory neocortex. B) 
Shows GFAP-IR in subependyma. C) Shows Co-localization of AQP9 and GFAP IR in yellow. D) Shows 
strong AQP9-IR (arrows) apical and basolateral membrane of bile duct of liver. E) Strong AQP9-IR 
between fimbria and lining of ventricle. F) Strong GFAP-IR between fimbria and lining of ventricle. G) 
Co-localization of AQP9 and GFAP IR in yellow between fimbria and lining of ventricle. AQP9-IR is 
shown in red (Alexa F 594 secondary Ab, primary anti-AQP 9 polyclonal Ab AQP91-A). Nuclei stained 
with DAPI (blue). Immunofluorescence was visualized with a 20X objective non confocal microscope in 
images in A, B and C. Non confocal 60X oil objective was used to obtain images in D, E, F and G. Scale 




















The CP secretes most of the CSF though mechanisms that are poorly understood 
(Damkier et al., 2013). The process of fluid secretion in CP involves transcellular water 
transport through CPECs, but the molecular nature of these water pathways is an 
unresolved matter. As already mentioned in the introduction of the present work, water 
flux via the lipid bilayers cannot explain the high rates of fluid secretion typical of 
CPECs. Two major cation-coupled cotransporters that “cotransport” water and ions are 
expressed in these cells, NKCC1 and KCC3a. However, under basal conditions these 
cotransporters work in the opposite direction to that expected for fluid secretion (see 
Fig.1). Another cation-coupled cotransporter, KCC4, which has the expected orientation 
for solute and fluid secretion (Fig. 1), is activated by osmotic cell swelling and thus, it is 
not clear if it is involved in water cotransport (reviewed in Alvarez-Leefmans, 2012). 
Thus, the most likely candidates for fluid secretion in CPECs are AQPs.  
Net water flux occurs from the basolateral membrane through the apical 
membrane of CPECs (Alvarez-Leefmans, 2012; Damkier et al., 2013). Thus, elucidation 
of the expression and localization of AQPs in CPECs constitutes a crucial step for 
understanding the molecular machinery involved in CSF secretion. However, with the 
exception of AQP1 in the apical membrane, the molecular pathways for transepithelial 
water transport are either unknown or their expression is controversial; there are no 
known AQPs in the basolateral membrane of CPECs to account for the influx of water, 





elucidated. The expression of AQP1 in the basolateral membrane is a subject of debate. 
Previous work from our lab confirmed the strict apical localization of AQP1; its 
expression in the basolateral membrane of mouse CPECs is undetectable (Crum and 
Alvarez-Leefmans, 2012). Thus, AQPs other than AQP1 are potential molecular 
substrates for the basolateral water influx. Further, it is not known if besides AQP1 there 
are other AQPs in the apical membrane that could participate in CSF secretion.  
In the present study, we began testing the hypothesis proposing that there must be 
AQPs other than AQP1 localized to the apical membrane and to the basolateral 
membrane. AQPs in the basolateral membrane could explain basolateral net water influx. 
Previously, our group detected the transcripts for several AQPs in whole choroid plexus 
tissue using RT-PCR (Cha et al., 2014). Those results are only a preliminary step because 
of possible contamination with ependymal and or glial cells. Nevertheless they provided 
the clues for investigating the expression of various water channel proteins in CPECs and 
EPCs. The AQPs identified at the transcript level were AQP0, AQP1, AQP2, AQP4, and 
aquaglyceroporins AQP3, AQP7 and AQP9, and “unorthodox” AQP 11. The present 
work was restricted to study the expression pattern of three of these AQPs: AQP4, AQP7 
and AQP9.  
 
Expression of AQP4 
The present work constitutes a detailed study of the cellular and subcellular 
distribution of AQP4 in CPECs and EPCs of LVs of mouse brain, using confocal 





and positive controls with tissues in which AQP4 expression is undisputed. In mice of 
different ages (P-12, 19, 20, 29 and 30) AQP4 was not expressed in CPECs (Fig. 13A), 
but rather in radial glial endings surrounding the basolateral aspect of EPCs (Fig. 15C), 
and in astrocytic end-feet surrounding blood vessels (Fig. 13A and 14A).   The 
expression of AQP4 in CPECs has been a controversial topic; different research groups 
report conflicting results using in situ hybridization (Hasegawa et al., 1993; Jung et al., 
1994, Venero et al, 1999) or immunocytochemistry (Nielsen et al., 1997; Speake et al., 
2003; Mobasheri et al., 2007; Nazari et al., 2015). The present results are consistent with 
in situ hybridization studies suggesting the absence of mRNA encoding AQP4 
(Hasegawa et al., 1993; Jung et al., 1994) but do not support similar observations by 
Venero’s group (Venero et al., 1999).  As for AQP4 protein expression, our results are in 
agreement with those of Nielsen’s group (Nielsen et al., 1997) but in sharp disagreement 
with studies proposing AQP4 protein expression in CPECs (Speake et al., 2003; 
Mobasheri et al., 2007; Nazari et al., 2015).  The antibodies used in the present study 
were validated against AQP4 -/- mouse tissues (Katada et al., 2014), and as positive 
controls we used mouse tissues where AQP4 expression is undisputed, such as the 
basolateral membranes of proximal tubules (Van Hoek et al., 2000) and in mouse skeletal 
muscle (Frigeri et al., 1995; Yang et al., 2000; Crosbie et al., 2002). Previous work for 
our group (Cha et al, 2014) detected AQP4 mRNA transcripts by RT-PCR analysis of 
whole CP tissue. This result is likely to be explained by contamination with ependymal or 
glial cells, during extraction of the CP from the IV ventricle of mouse brain.  
We have found the expression of AQP4 in endings of radial glial cells (glia 





previous studies (Frigeri et al., 1995; Rash et al., 1998). For review see (Nagelhus and 
Ottersen, 2013, Papadopoulos and Verkman, 2013). This specific distribution of AQP4 
suggests that it plays an important role in water (and ion) transport at the brain–CSF 
interface, i.e. the ependyma, perhaps in K+ clearance from CSF. This intriguing 
possibility motivated us to further examine the coexpression of AQP4 and NKCC1 in 
ependymal and subependymal regions, given that NKCC1 has properties that make it 
suitable as an extracellular K+ uptake mechanism (Alvarez-Leefmans, 2012).  
 
Co-expression of AQP4 and NKCC1  
Given the distribution of AQP4-IR in glial processes ending between and around 
ependymal cells we searched for the possible coexpression with NKCC1. We 
hypothesized that NKCC1 might be colocalized with AQP4 not only in the astrocytic 
perivascular endfeet but also in the ventricular endings of radial glia. The results show 
that AQP4 colocalized with NKCC1 in both the radial glial endings surrounding the basal 
aspect of EPCs (Fig 15A, B and C), and in astrocytic perivascular endfeet (Figs 14A and 
15A).  Interestingly, we also found the expression of NKCC1 in the apical membrane of 
EPCs (Fig 14A and 15A). The antibodies used in this study were validated against 
NKCC1 -/- mouse tissues, and as positive controls we used choroid plexus epithelium 
itself. In epithelial cells NKCC1 is expressed in the basolateral membrane except for 
CPECs where it adopts an apical location. To the list of NKCC1 expression exceptions in 





cells where it may play a role in cell volume maintenance and K+ buffering of CSF and 
brain interstitial fluid.  
Radial glial cells, astrocytes and CPECs are believed to play a significant role in 
K+ uptake in CNS (Abbott et al, 2006; Nagelhus and Ottersen, 2013) and CSF 
respectively (Wu et al., 1998; Alvarez-Leefmans, 2012). We found colocalization of 
NKCC1 and glial fibrillary acidic protein in radial glial endings surrounding EPCs and in 
astrocytes of cortex, hippocampus and corpus callosum of mouse brain, consistent with 
previous studies showing coexpression of NKCC1 with glial cells  (Yan et al 2001a,b).  It 
has long been proposed that astrocytes and other glial cells have a major role in buffering 
extracellular K+ by transferring these ions released by active neurons in the CNS to blood. 
Thus, glial cells uptake excess extracellular K+, which can be transported to other 
locations where extracellular K+ concentrations are lower or these ions are released at the 
endfeet of perivascular astrocytes forming the BBB, where they are transported to blood 
vessels (Paulson and Newman, 1987).  
What is the functional significance of these findings? Two recent papers 
addressing the functional aspects of the proteins thought to be involved in K+ clearance, 
coauthored by Nana MacAulay (Macaulay and Zeuthen, 2012; Larsen et al, 2014) serve 
as example of the current controversies on the functional role of the triad formed by 
AQP4, inward rectifier K+ channels (Kir) and NKCC1 on extracellular K+ buffering by 
astrocytes. They postulated two different views that are contradictory: i) K+ clearance 
from the extracellular space is likely to be achieved by the coordinated action of AQPs 
and NKCC1 (Macaulay and Zeuthen, 2012). ii) Later, in 2014, Larsen and coworkers 





results they presented were not convincing (Larsen et al, 2014).  The controversy about 
the role of NKCC1 in conjunction with AQP4 in K+ uptake in the CNS is further 
illustrated by two letters to the Editor published in the Journal of General Physiology in 
2013, one supporting the role of NKCC1  (Hertz et al, 2013) and the other challenging it 
(Jin et al, 2013). The present findings showing AQP4 and NKCC1 co-expression strongly 
suggest a role of NKCC1 in K+ uptake from the cerebrospinal fluid, thus buffering and 
regulating K+ in CSF and brain interstitial fluid. 
The schematic diagram of Fig. 18 illustrates the distribution of AQP4 and 
NKCC1 in the endings of radial astrocytes and in EPCs. AQP4 and NKCC1 are present 
in the endings of radial astrocytes (green) forming calyx-like structures around the 
basolateral aspect of ependymal cells (yellow). Also, illustrated in Fig. 18 is the 
expression of NKCC1 in the apical membrane of ependymocytes. 
 






























Figure 18. Diagram illustrating the distribution of AQP4 and NKCC1 in the endings of radial glia 
and in the ependyma. The drawing summarizes the results obtained by immunolabeling experiments 
aimed at determining the sub-cellular localization of AQP4 and NKCC1 colocalized with GFAP. AQP4 
and NKCC1are present in the endings of glial cells, probably radial glia or tanycytes (green), which are 
encroaching the ependymal cells (yellow). The drawing also illustrates the expression of NKCC1 in the 
apical membrane of EPCs. The dyad AQP4-NKCC1 may play a significant role K+ regulation of CSF. 
 
 
Expression of AQP7 
The studies aimed at determining the subcellular distribution of AQP7 in CPECs 





and EPCs. (Fig. 16A). The antibodies used in this work have been validated in previous 
studies (Laforenza et al., 2010, 2013; Goubau et al., 2013; Hermo et al., 2008; Aure et al., 
2014).  As positive controls we used mouse tissues where AQP7 expression is well 
established like mouse skeletal myofibers (Wakayama et al 2014) and apical (brush 
border) membrane of the proximal tubules of mouse kidney (Nejsum et al, 2000).  
Our results are in agreement with a previous study claiming AQP7 expression in 
CPECs but its specific subcellular localization i.e. apical or basal membrane on CPECs 
was not discerned Shin et al, 2006). The present study shows, for the first time, the 
subcellular localization of AQP7 in CPECs. AQP7 is largely expressed in the apical 
membrane of CPECs and in varying degree of in ependyma of LV of mouse brain. AQP7 
was undetected in basolateral membrane of CPECs. This suggests that AQP7 could work 
together with AQP1 in CSF secretion in CP. 
 
Expression of AQP9 
We present a detailed immunolabeling and confocal immunofluorescence study of 
the distribution of AQP9 in CPECs and EPCs of LV mouse brain in seven different mice 
of ages P-12, 19, 20, 29 and 30. AQP9 is expressed neither in apical nor in basolateral 
membrane of CPECs (Fig. 17A). Thus, the water pathways for water influx across the 
CPECs basolateral membrane remain to be elucidated. However, we have found the 
expression of AQP9 in radial glial cells and in the subependymal zone (Fig. 18 B, C). 
The antibodies used in this study were validated against AQP9 -/- mouse tissues 
(Mylonakou et al., 2009), and as positive controls we used mouse liver tissues where 





Our findings on AQP9 expression in radial glial (Fig. 18E, F and G) and tanycytes are in 
agreement with previous studies (Elkjaer et al., 2000, Badaut et al., 2001). 
This specific distribution of AQP9 suggests that it may play a role in water transport at 





















1) Validated antibodies against AQP4 revealed that this protein is not expressed in 
CPECs.  
2) Ependymal AQP4 is not expressed in ependymocytes but in the endings of radial glia       
surrounding the basal aspect of the ependymal cells. In this location AQP4 is co-
expressed with NKCC1.  
3) The data confirm NKCC1 expression in the apical membrane of CPECs and shows for 
the first time that NKCC1 is also expressed in the apical membrane of lateral ventricle 
ependymal cells.  
4) The expression of NKCC1 in the apical membrane of EPCs and its colocalization with 
AQP4 at the ventricular endings of radial glia suggest NKCC1 could play a role in CSF 
and brain interstitial fluid K+ homeostasis. 
5) AQP7 is expressed in the apical membrane of CPECs and EPCs suggesting that 
together with AQP1 may be involve in CSF secretion.  
6) AQP9 was found in the subependymal region coexpressed with the glial marker 
GFAP. AQP9 is expressed neither in CPECs nor in EPCs. 
7) The AQP expected to be expressed in the basolateral membrane of CPECs remains to 
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